State Laws Can Promote Hepatitis C Virus Screening

Share this content:
State Laws Can Promote Hepatitis C Virus Screening
State Laws Can Promote Hepatitis C Virus Screening

MONDAY, Oct. 2, 2017 (HealthDay News) -- Mandating health care providers to offer hepatitis C virus (HCV) screening can increase screening rates and linkage to care among those with newly diagnosed infection, according to research published in the Sept. 29 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Noting that in 2014 New York enacted a law requiring health care providers to offer HCV antibody screening to those born from 1945 to 1965, Colleen A. Flanigan, R.N., from the New York State Department of Health in Albany, and colleagues used survey data from clinical laboratories and Medicaid claims and encounter data, as well as HCV surveillance data, to examine the number of individuals tested for HCV and linkage with care among those with newly diagnosed HCV infection.

The researchers observed a 51 percent increase in specimens submitted for HCV testing during the first year of the HCV law implementation; among active Medicaid clients, testing rates increased 52 percent. There was an increase in linkage to care among persons with newly diagnosed HCV infection, by approximately 40 percent in the state of New York and 11 percent in New York City.

"These findings highlight the potential for state laws to promote HCV testing and the utility of HCV surveillance and Medicaid claims data to monitor the quality of HCV testing and linkage to care for HCV-infected persons," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »